PATENT CLAIM ANALYSIS

Application Number: 15880724
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
A preventive and/or therapeutic agent for systemic lupus erythematosus comprising an anti-interleukin-6 (IL-6) receptor antibody as an active ingredient.

Claim (Index 6):
The preventive and/or therapeutic agent according to any of  claims 1  to  5  wherein the anti-IL-6 receptor antibody is a recombinant IL-6 receptor antibody.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12382160', '10554407', '13700355', '09762550', '10596429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6630040733921352
- 35 USC 102 Novelty (BERT): 0.5032195535741887
- Combined Prediction Score: 0.6470256214103406
- Mean Citation Score: 258.61271400000004
- Max Citation Score: 268.45248
- Similarity Product: 230.76650613189696

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test